Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.21
-0.06 (-0.49%)
At close: Aug 18, 2025, 3:59 PM
12.23
0.12%
After-hours: Aug 18, 2025, 06:19 PM EDT

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals reported an annual revenue of $235.13M, reflecting a 33.97% growth. For the quarter ending June 30, 2025, Aurinia Pharmaceuticals generated $70.01M in revenue.
Revenue (ttm)
235.13M
Revenue Growth
33.97%
Price / Sales Ratio
5.46
Revenue / Employee
1.81M
Employees
130
Market Cap
1.61B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 235.13M +33.97%
Dec 31, 2023 175.51M +30.95%
Dec 31, 2022 134.03M +193.89%
Dec 31, 2021 45.6M -9.00%
Dec 31, 2020 50.12M +15660.38%
Dec 31, 2019 318K -31.32%
Dec 31, 2018 463K +10.24%
Dec 31, 2017 420K +142.77%
Dec 31, 2016 173K -26.38%
Dec 31, 2015 235K -15.47%
Dec 31, 2014 278K -70.69%
Dec 31, 2013 948.56K -84.60%
Dec 31, 2012 6.16M +563.90%
Dec 31, 2011 927.52K -72.88%
Dec 31, 2010 3.42M -15.59%
Dec 31, 2009 4.05M +4.52%
Dec 31, 2008 3.88M +66.05%
Dec 31, 2007 2.33M -33.72%
Dec 31, 2006 3.52M +199.06%
Dec 31, 2005 1.18M -7.51%
Dec 31, 2004 1.27M -83.38%
Dec 31, 2003 7.66M -35.71%
Dec 31, 2002 11.92M +124.97%
Dec 31, 2001 5.3M +486.77%
Nov 30, 2000 902.77K -33.53%
Nov 30, 1999 1.36M +73.85%
Nov 30, 1998 781.25K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.